Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and Liver Diseases

carbapenems has been researched along with Liver Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Jian, C; Li, Y; Ni, M; Ning, Q; Song, J; Tian, F; Wang, Y; Yu, B1
Hata, K; Ichiyama, S; Iida, T; Kaido, T; Okajima, H; Sato, A; Takakura, S; Uemoto, S; Yagi, S1
Chang, HJ; Chia, JH; Hsu, PC; Kuo, AJ; Lee, MH; Wu, TL; Yang, CC1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW1

Other Studies

4 other study(ies) available for carbapenems and Liver Diseases

ArticleYear
Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
    Annals of clinical microbiology and antimicrobials, 2023, Jan-29, Volume: 22, Issue:1

    Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Liver Diseases; Molecular Epidemiology; Multilocus Sequence Typing; Risk Factors

2023
Bundled strategies against infection after liver transplantation: Lessons from multidrug-resistant Pseudomonas aeruginosa.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2016, Volume: 22, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Calcitonin; Carbapenems; Clinical Protocols; Drug Resistance, Multiple, Bacterial; Female; Hand Hygiene; Humans; Incidence; Infection Control; Japan; Length of Stay; Liver Diseases; Liver Transplantation; Living Donors; Male; Middle Aged; Pseudomonas aeruginosa; Treatment Outcome; Young Adult

2016
Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Regression Analysis; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome; Uremia

2011
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitalization; Humans; Intraabdominal Infections; Liver Diseases; Longitudinal Studies; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan; Time Factors

2012